Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Risk Communication Advisory Committee

This article was originally published in The Tan Sheet

Executive Summary

FDA is requesting nominations for membership to its new advisory committee. Comprising 15 voting members, the committee will advise the agency on ways to better communicate the risks and benefits of FDA-regulated products. FDA formed the advisory group in response to recommendations by the Institute of Medicine's 2006 report, "The Future of Drug Safety: Promoting and Protecting the Health of the Public"...
Advertisement

Related Content

FDA Risk Communication Panel’s Charter Is Tweaked As Members Are Named

Topics

Advertisement
UsernamePublicRestriction

Register

PS100602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel